M. Marien

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Agnès L. Auclair, J.-C. Martel, M.B. Assié et al. · Neuropharmacology · 2013 · 262 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease

M. Mavridis, A.‐D. Degryse, A. Lategan et al. · Neuroscience · 1991 · 213 citations

Life Sciences, Neurology, Neuroscience +17

Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography

C. Anthony Altar, M. Marien · Journal of Neuroscience · 1987 · 104 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

M. Marien, Stanley M. Parsons, C. Anthony Altar · Proceedings of the National Academy of Sciences · 1987 · 65 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Intracerebral dialysis: Direct evidence for the utility of 3-MT measurements as an index of dopamine release

Paul L. Wood, H.S. Kim, M. Marien · Life Sciences · 1987 · 56 citations

Life Sciences, Neurology, Neuroscience +5